scholarly journals Improved Sensitivity of Human Immunodeficiency Virus Type 2 Subtype B Plasma Viral Load Assay

2005 ◽  
Vol 43 (8) ◽  
pp. 4234-4236 ◽  
Author(s):  
F. Damond ◽  
G. Collin ◽  
D. Descamps ◽  
S. Matheron ◽  
S. Pueyo ◽  
...  
2002 ◽  
Vol 40 (10) ◽  
pp. 3654-3659 ◽  
Author(s):  
F. Damond ◽  
M. Gueudin ◽  
S. Pueyo ◽  
I. Farfara ◽  
D. L. Robertson ◽  
...  

2009 ◽  
Vol 83 (19) ◽  
pp. 10269-10274 ◽  
Author(s):  
Anne Piantadosi ◽  
Dana Panteleeff ◽  
Catherine A. Blish ◽  
Jared M. Baeten ◽  
Walter Jaoko ◽  
...  

ABSTRACT The determinants of a broad neutralizing antibody (NAb) response and its effect on human immunodeficiency virus type 1 (HIV-1) disease progression are not well defined, partly because most prior studies of a broad NAb response were cross-sectional. We examined correlates of NAb response breadth among 70 HIV-infected, antiretroviral-naïve Kenyan women from a longitudinal seroincident cohort. NAb response breadth was measured 5 years after infection against five subtype A viruses and one subtype B virus. Greater NAb response breadth was associated with a higher viral load set point and greater HIV-1 env diversity early in infection. However, greater NAb response breadth was not associated with a delayed time to a CD4+ T-cell count of <200, antiretroviral therapy, or death. Thus, a broad NAb response results from a high level of antigenic stimulation early in infection, which likely accounts for prior observations that greater NAb response breadth is associated with a higher viral load later in infection.


1999 ◽  
Vol 15 (6) ◽  
pp. 603-608 ◽  
Author(s):  
Danuta Pieniazek ◽  
Dennis Ellenberger ◽  
Luiz M. Janini ◽  
Artur C. Ramos ◽  
John Nkengasong ◽  
...  

Medicine ◽  
2019 ◽  
Vol 98 (6) ◽  
pp. e14313 ◽  
Author(s):  
Christopher Z. Abana ◽  
Kwamena W.C. Sagoe ◽  
Evelyn Y. Bonney ◽  
Edward K. Maina ◽  
Ishmael D. Aziati ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document